中国平行进口汽车供应商 Cheetah Net，递交招股书，拟美国纳斯达克IPO上市

Original Ryanben Capital 瑞恩资本RyanbenCapital 2024-02-17

2023年4月7日，平行进口汽车供应商Cheetah Net Supply Chain Service Inc.(以下简称“Cheetah Net”)在美国证监会(SEC)提交更新的招股书，拟于美国纳斯达克IPO上市，股票代码CTNT。其早于2022年12月16日在SEC秘密递表。

Cheetah Net 招股书链接：

https://www.sec.gov/Archives/edgar/data/1951667/000110465923043141/tm2232193d4_s1.htm

主要业务

Cheetah Net ，创立于2016年，总部位于美国北卡罗来纳州Charlotte，作为一家平行进口汽车供应商，主要从美国市场购买汽车(主要是奔驰、宝马、保时捷、雷克萨斯和宾利等豪华品牌)，然后将它们转售给公司的客户(包括美国和中国的平行进口汽车经销商)。公司的利润主要来自于购买和出售平行进口汽车之间的价格差。

股东架构

招股书显示，Cheetah Net 在上市前的股东架构中，其股份包括A类股份(每股A类股份拥有1票投票权)841.6万股、B类股份(每股B类股份拥有15票投票权)825.0万股，股份合计1,666.6万股。

其主要股东包括：

刘桓 Huan Liu，通过FAIRVIEW EASTERN INTERNATIONAL HOLDINGS LIMITED持有B类股份825.0万股、占B类股份的100%，占全部股份的49.50%、拥有93.63%的表决权；

黄向耿 Xianggeng Huang，持有A类股份225万股、占A类股份的26.73%，占全部股份的13.50%、拥有1.70%的表决权；

Xiaolin Tang，持有A类股份150万股、占A类股份的17.82%，占全部股份的9.00%、拥有1.13%的表决权；

Yan Xiao，持有A类股份150万股、占A类股份的17.82%，占全部股份的9.00%、拥有1.13%的表决权；

Yingchang Yuan，通过Grand Bright International Holdings Limited持有A类股份120万股、占A类股份的14.26%，占全部股份的7.20%、拥有0.91%的表决权；

Huoyuan Chen，通过RAPID PROCEED LIMITED持有A类股份100万股、占A类股份的11.88%，占全部股份的6.00%、拥有0.76%的表决权；

Yan Bai，持有A类股份66.6万股、占A类股份的7.91%，占全部股份的4.00%、拥有0.50%的表决权。

公司架构

招股书显示，Cheetah Net 的公司架构如下：

管理层

招股书显示，Cheetah Net 的管理层如下：

刘桓 Mr. Huan Liu has served as our Chief Executive Officer and our Chairman of the Board of Directors since August 2016, and he has extensive experience in real estate, private equity, and car imports and exports. As the founder and CEO of Cheetah Net, Mr. Liu has been responsible for the management of day-to-day operations and high-level strategizing and business planning, as well as implementing proposed plans and evaluating the success of our Company in achieving its objectives. From 2014 to 2015, Mr. Liu served as the chief executive officer at Beijing Xinyongjia Technology Co., where he was responsible for identifying opportunities for expansion and analyzing operations to identify areas in need of reorganization. From 2012 to 2013, Mr. Liu served as the senior investment manager at Beijing Wanze Investment Management Co. Ltd., and was responsible for developing and implementing risk-based asset allocation models and performance analytics. Mr. Liu received his master’s degree in Finance from the International Business School at Brandeis University in 2012, and his bachelor’s degree in Finance and Law from Harbin Engineer University in 2005.

Mr. Robert Cook has served as our Chief Financial Officer since October 2022. He has extensive experience in corporate finance, SEC reporting, public accounting, investor relations, and corporate administration including management of internal controls. Mr. Cook is the founder and principal of RWC Consulting, LLC, a financial consulting company established in December 2016, where he is responsible for advising management and boards of directors of public and private companies on pre- and post-IPO financing opportunities. From June 2020 until April 2021, Mr. Cook served as the chief financial officer and corporate secretary of RenovaCare, Inc. (OTC: RCAR), where he was responsible for all financial functions, investor and public relations, and corporate administration including his duties as corporate secretary, From February 2017 to February 2020, Mr. Cook served as the chief financial officer at CorMedix Inc. (Nasdaq: CRMD) and was in charge of the company’s overall financial management, investor and public relations, and business development. From January 2016 to June 2016, Mr. Cook served as the chief financial officer at BioBlast Pharma Ltd. (Nasdaq: ORPN), where he was responsible for all financial functions, investor relations, and corporate administration. Mr. Cook also served as the chief financial officer at several other Nasdaq-listed companies, including Strata Skin Science Inc. (Nasdaq: SSKN) from April 2014 to January 2016, Immune Pharmaceuticals Inc. (Nasdaq: IMNP) from August 2013 to April 2014 and its predecessor EpiCept Corporation from April 2004 until August 2013, including one year as the company’s interim chief executive officer, and Pharmos Corporation (Nasdaq: PARS) from December 1997 to April 2004, respectively. Mr. Cook received his bachelor’s degree in International Finance from Kogod School of Business of the American University in 1977.

黄向耿 Mr. Xianggeng Huang will serve as our director starting immediately prior to the effectiveness of our registration statement of which this prospectus is a part. From 2003 to 2022, Mr. Huang served as the chairman of the board of directors of Fuzhou Yisheng Mechanical and Electrical Equipment Co., Ltd.(福州谊升机电设备有限公司), where he was responsible for running the board of directors, consulting the executives on issues, challenges, and opportunities facing the company, and high-level strategizing and business planning. From 1999 to 2002, Mr. Huang served as a general manager of the Fujian branch of Kone Elevator Co., Ltd., a Finish elevator manufacturer. From 1997 to 1999, he served as a major project manager at Otis Elevator China Co., Ltd. Mr. Huang received his bachelor’s degree in Automated Machinery from Nanjing University of Science and Technology in 1984.

公司业绩

招股书显示，在过去的2021年、2022年，Cheetah Net的收入分别为3,920.40万、5,515.33万美元，相应的净利润分别为117.02万、81.70万美元。

中介机构